HISTO
Latest round
- Series B
Last raised
- May 2024
Total raised
- Undisclosed
Investors
- 5
About HISTO
Established in 2011 and based in Shanghai, China, HistoMed is an institution in the field of pathology diagnostics. The company has expanded its operations with branches and centers in various locations, including a pathology center in Beijing, and also has a 5,700 square meter laboratory. The company also provides genome chips platform with more than 20 intelligent reports about molecular pathology of cancer species. Besides, the company has media platform for expertise communication. The company offers a wide range of pathology services, including digital remote diagnostics, frozen biopsy, histological pathology diagnosis, cytological pathology diagnosis, immunohistochemistry and special staining, molecular pathology differential diagnosis, and companion diagnostics for various precision treatments. The company's services are geared towards providing solutions for routine pathology diagnostics, expert consultations, and pharmaceutical standardization services, enabling nationwide sharing of diagnostic resources. The company generates revenue by providing pathology diagnostic services, digital pathology solutions, and collaborating with pharmaceutical companies and healthcare institutions for standardized services and clinical trials.
Who invested in HISTO
5 investors across 2 rounds
See all investors in HISTO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HISTO
Who invested in HISTO?
HISTO has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HISTO raised?
HISTO has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did HISTO last raise money?
HISTO's most recent round on record is a Series B, in May 2024.
What does HISTO do?
Established in 2011 and based in Shanghai, China, HistoMed is an institution in the field of pathology diagnostics.
Where is HISTO headquartered?
HISTO is headquartered in Shanghai, China.
Which VCs invest in companies like HISTO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at HISTO's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like HISTO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.